Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

U 37883A

Known as: U 37883, U-37883, U-37883A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Background and purpose:  Intermedin (IMD) is a newly identified member of the calcitonin family of peptides that shares… 
Review
2006
Review
2006
  • N. Teramoto
  • Cardiovascular drug reviews
  • 2006
  • Corpus ID: 35449553
U-37883A (PNU-37883A, guanidine; 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexyl hydrochloride) was originally developed as… 
2002
2002
1. Endomorphins 1 and 2, endogenous ligands for the μ‐opioid receptor, and nociceptin (orphanin FQ; OFQ), an endogenous ligand… 
Highly Cited
2002
Highly Cited
2002
Calcium-sensitizing drugs, such as levosimendan, are a novel class of drug therapy for heart failure. We investigated the… 
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
1999
1999
Background: Although a great deal is known about responses to propofol, controversy remains about its mechanism of action. The… 
1996
1996
The effects of the vascular selective nonsulfonylurea guanidine ATP-sensitive K+ (KATP+) channel-blocking agent U-37883A on… 
Highly Cited
1995
Highly Cited
1995
The present study investigates the effects of human adrenomedullin (ADM) on the pulmonary vascular bed of isolated, blood… 
1994
1994
Follicle-enclosed Xenopus oocytes were used to describe the ATP-sensitive K+ (KATP) channel-blocking properties of U-37883A (4… 
1993
1993
This study describes the in vitro and in vivo characteristics of a guanidine 4-morpholinecarboximidine-N-1-adamantyl-N…